Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma

Overview of attention for article published in OncoTargets and therapy, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,873 followers.

RT @Lymphoma_Papers: Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. #lymphoma #lymsm https://t.co…

RT @Lymphoma_Papers: Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. #lymphoma #lymsm https://t.co…

RT @Lymphoma_Papers: Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. #lymphoma #lymsm https://t.co…

Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. #lymphoma #lymsm https://t.co/hxNkzlrJry